在人类癌症中UBE2T的生物学功能和治疗潜力
Keshen Wang1, Qichen He1, Xiangyan Jiang1
1Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu, 730030, China.
Current cancer drug targets
|March 7, 2025
概括
无素-蛋白酶体系统调节细胞过程. 本综述考察了癌症中的泛素结合酶E2T (UBE2T),突出了其治疗潜力.
科学领域:
- 生物化学和分子生物学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 无素-蛋白酶体系统 (UPS) 对于蛋白质稳态和真核生物的信号传递至关重要.
- 乌比基因结合酶 (E2s) 是UPS的关键组成部分,E2酶 (E3s) 传统上被视为基质特异性的决定因素.
- 除了E3结合酶之外,E2酶的调节失调越来越多地与癌症等病理有关.
研究的目的:
- 综合审查泛素结合酶E2T (UBE2T) 的作用和机制.
- 探索UBE2T在癌症发病,进展和治疗耐药性的参与.
- 突出UBE2T作为癌症治疗的潜在治疗标.
主要方法:
- 对UBE2T功能现有研究的文献综述.
- 对UBE2T在无处不在途径中的机械作用的分析.
- 检查UBE2T对各种癌症类型和治疗反应的影响.
主要成果:
- UBE2T在癌症的发展和进展中起着重要的作用.
- UBE2T活动与治疗耐药性机制有关.
- 有证据表明,UBE2T失调有助于病理结果.
结论:
- UBE2T是癌症发病的关键参与者.
- 准UBE2T为癌症提供了一个有前途的治疗策略.
- 对UBE2T机制的进一步研究可以解锁新的抗癌治疗方法.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Electron Transport Chain: Complex I and II
10.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.0K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457


